Yves Sucaet, co-founder, CTO, PhD, Bioinformatician
Dr. Sucaet holds a PhD in bioinformatics from Iowa State University. His research background is in systems and network biology. He’s a co-founder of Pathomation and currently fulfills the role of Chief Technology Officer. Before that, he was at HistoGeneX in the function of Section Head Data Management & Bioinformatics, where he met Dr. Waelput. They decided to combine their knowledge and have been promoting the use of digital pathology since.
Wim Waelput, co-founder, MD, PhD, Pathologist.
Dr Waelput is a M.D. and certified pathologist, currently employed as a senior staff member at the University Hospital of Brussels (UZ-Brussel). He’s also consulting (pharma-)pathologist at Histogenex and co-founder of Pathomation BVBA. Dr. Waelput has been involved in research on protein-protein interactions and signal transduction within the department of medical protein research of the VIB (Vlaams Instituut voor Biotechnologie) where he obtained legal degree of doctor in the Medical Sciences (PhD).
Mark Kockx, co-founder, MD, PhD, Pathologist
Dr. Kockx is managing director at HistoGeneX, a contract research organization (CRO) focused on oncology and biomarker-development and –validation. Histological techniques are a major part of their portfolio, and as such HistoGeneX is constantly on the lookup to optimize their digital workflow. Dr. Kockx played a major role in deciding that a software project would be more successful when spun off as a separate company.